Page last updated: 2024-08-17

uridine and Leukemia, Myelomonocytic, Chronic

uridine has been researched along with Leukemia, Myelomonocytic, Chronic in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	4 (80.00)	2.80

Authors

Authors	Studies
Azab, M; Brandwein, J; Busque, L; DeZern, AE; Garcia-Manero, G; Griffiths, EA; Kantarjian, H; McCloskey, J; Michaelis, LC; O'Connell, C; Odenike, O; Oganesian, A; Roboz, GJ; Savona, MR; Steensma, DP; Wells, R; Yee, K	1
Dhillon, S	1
Azab, M; Griffiths, EA; Oganesian, A; Thota, S	1
Cahill, K; Odenike, O; Patel, AA; Saygin, C	1
Duchmann, M; Itzykson, R	1

Reviews

4 review(s) available for uridine and Leukemia, Myelomonocytic, Chronic

Article	Year
Decitabine/Cedazuridine: First Approval. Drugs, 2020, Volume: 80, Issue:13 Topics: Administration, Oral; Adult; Canada; Clinical Trials as Topic; Decitabine; Drug Approval; Drug Combinations; Drug Development; History, 21st Century; Humans; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; United States; United States Food and Drug Administration; Uridine	2020
Role of cedazuridine/decitabine in the management of myelodysplastic syndrome and chronic myelomonocytic leukemia. Future oncology (London, England), 2021, Volume: 17, Issue:16 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Decitabine; Disease Management; Drug Approval; Humans; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Treatment Outcome; Uridine	2021
Cedazuridine/decitabine: from preclinical to clinical development in myeloid malignancies. Blood advances, 2021, 04-27, Volume: 5, Issue:8 Topics: Azacitidine; Decitabine; Humans; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Uridine	2021
Clinical update on hypomethylating agents. International journal of hematology, 2019, Volume: 110, Issue:2 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Clinical Trials as Topic; Decitabine; DNA Methylation; Drug Administration Schedule; Drug Combinations; Gene Expression Regulation, Leukemic; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Uridine	2019

Trials

1 trial(s) available for uridine and Leukemia, Myelomonocytic, Chronic

Article	Year
Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study. Blood, 2020, 08-06, Volume: 136, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Capsules; Cross-Over Studies; Decitabine; Disease Progression; DNA Methylation; DNA-Cytosine Methylases; Drug Combinations; Drug Monitoring; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Kaplan-Meier Estimate; Least-Squares Analysis; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Long Interspersed Nucleotide Elements; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasm Proteins; Tablets; Uridine	2020

Article

Year

Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study.

Blood, 2020, 08-06, Volume: 136, Issue:6

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Capsules; Cross-Over Studies; Decitabine; Disease Progression; DNA Methylation; DNA-Cytosine Methylases; Drug Combinations; Drug Monitoring; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Kaplan-Meier Estimate; Least-Squares Analysis; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Long Interspersed Nucleotide Elements; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasm Proteins; Tablets; Uridine

2020